WuXi AppTec’s Changzhou and Taixing API Sites Successfully Pass FDA Inspections

SHANGHAI, March 31, 2025 /PRNewswire/ — WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences industry, today announced that its Active Pharmaceutical Ingredient (API) manufacturing…